Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

David Kershenobich-Stalnikowitz1

  • 1Secretario de Salud. México.. correo@correo.com.

Salud publica de Mexico
|October 28, 2025
PubMed
概括
此摘要是机器生成的。

这项研究是不可用的.

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Granulomatous liver disease in a referral center in Mexico city.

Annals of hepatology·2025
Same author

Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study.

Therapeutic advances in infectious disease·2024
Same author

Burden of disease due to liver cirrhosis in Mexico.

Gaceta medica de Mexico·2024
Same author

Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2023
Same author

Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study.

Open forum infectious diseases·2022
Same author

Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis.

Gastroenterologia y hepatologia·2022

科学领域:

  • 没有信息可用.

背景情况:

  • 没有信息可用.

研究的目的:

  • 没有信息可用.

主要方法:

  • 没有信息可用.

主要成果:

  • 没有信息可用.

结论:

  • 没有信息可用.